CanniMed receives Health Canada's approval to produce medical cannabis capsules
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
Health Canada granted CanniMed Therapeutics Inc. license to produce medical cannabis capsules.
The company has initiated production of its CanniMed capsules following receipt of the production license.
